LCIG in treatment of non‐motor symptoms in advanced Parkinson’s disease: Review of literature
Sign Up to like & getrecommendations! Published in 2020 at "Brain and Behavior"
DOI: 10.1002/brb3.1757
Abstract: For managing nonmotor symptoms (NMS) in advanced Parkinson's disease (PD), levodopa–carbidopa intestinal gel (LCIG) infusion is of interest as it shows lesser plasma fluctuations of both drugs as compared to oral levodopa–carbidopa (LC). read more here.
Keywords: treatment non; non motor; lcig treatment; parkinson disease ... See more keywords